Joseph E. McClellan
Technik-/Wissenschafts-/F&E-Leiter bei ALVOTECH
Vermögen: - $ am 30.04.2024
Profil
Joseph E.
McClellan is currently the Chief Scientific Officer at Alvotech hf and Alvotech.
Previously, he worked at Pfizer Inc. as the Global Head-Biosimilars Development & Medicine.
McClellan completed his undergraduate degree at the College of the Holy Cross (Massachusetts), his doctorate at the University of Florida, and his MBA at Northeastern University (China).
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ALVOTECH
-.--% | 15.02.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Joseph E. McClellan
| Unternehmen | Position | Beginn |
|---|---|---|
| ALVOTECH | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2019 |
Alvotech hf
 Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2019 |
Ehemalige bekannte Positionen von Joseph E. McClellan
| Unternehmen | Position | Ende |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | - |
Ausbildung von Joseph E. McClellan
| University of Florida | Doctorate Degree |
| College of the Holy Cross (Massachusetts) | Undergraduate Degree |
| Northeastern University (China) | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ALVOTECH | Health Technology |
| PFIZER, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | Health Technology |
